
Blood Lancet Market by Type (Home Care Lancet, Safety Lancets, Standard Lancets), Gauze Size (22G, 31 G, Above 38 G), Age Group, End-Users, Application - Global Forecast 2023-2030
Description
Blood Lancet Market by Type (Home Care Lancet, Safety Lancets, Standard Lancets), Gauze Size (22G, 31 G, Above 38 G), Age Group, End-Users, Application - Global Forecast 2023-2030
The Blood Lancet Market is projected to reach USD 3.85 billion by 2030 from USD 1.67 billion in 2022, at a CAGR of 11.02% during the forecast period.
Market Segmentation & Coverage:
This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Blood Lancet Market.
- Based on Type, market is studied across Home Care Lancet, Safety Lancets, and Standard Lancets. The Safety Lancets is further studied across Manually and Pressure Activated. The Safety Lancets is projected to witness significant market share during forecast period.
- Based on Gauze Size, market is studied across 22G, 31 G, Above 38 G, and Below. The Below is projected to witness significant market share during forecast period.
- Based on Age Group, market is studied across Adult and Pediatrics. The Pediatrics is projected to witness significant market share during forecast period.
- Based on End-Users, market is studied across Blood Banks, Home Care, and Hospitals & Clinics. The Hospitals & Clinics is projected to witness significant market share during forecast period.
- Based on Application, market is studied across Cholesterol Testing, Glucose Testing, and Hemoglobin Testing. The Cholesterol Testing is projected to witness significant market share during forecast period.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas is projected to witness significant market share during forecast period.
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix is an indispensable tool for assessing the Blood Lancet Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.
Market Share Analysis:
The Market Share Analysis offers invaluable insights into the vendor landscape Blood Lancet Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.
Key Company Profiles:
The report delves into recent significant developments in the Blood Lancet Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACON Laboratories, Inc., AdvaCare Pharma, AMBISEA Technology Corp., Ltd., Amkay Products Pvt. Ltd., B. Braun Melsungen AG, Becton, Dickinson & Company, BioCare Corporation, CML Biotech Ltd., F. Hoffmann-La Roche AG, FL MEDICAL s.r.l., Haemonetics Corporation, Improve Medical, Natus Medical by ARCHIMED, Nipro Medical Corporation, Owen Mumford Ltd., SARSTEDT AG & Co. KG, Shandong Lianfa Medical Plastic Products Co., Ltd., SteriLance Medical (Suzhou) Inc., Terumo Corporation, and Ypsome AD.
The report offers valuable insights on the following aspects:
- Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
- Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
- Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
- Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
- Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast for the Blood Lancet Market?
- Which products, segments, applications, and areas hold the highest investment potential in the Blood Lancet Market?
- What is the competitive strategic window for identifying opportunities in the Blood Lancet Market?
- What are the latest technology trends and regulatory frameworks in the Blood Lancet Market?
- What is the market share of the leading vendors in the Blood Lancet Market?
- Which modes and strategic moves are suitable for entering the Blood Lancet Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
192 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Blood Lancet Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Prevalence of diabetes among individuals and need for enhanced care
- 5.1.1.2. High availability of lancet through online distribution channels
- 5.1.1.3. Government initiatives in diabetes check up campaigns
- 5.1.2. Restraints
- 5.1.2.1. Inaccuracy in skin puncture and safety issues associated with lancet
- 5.1.3. Opportunities
- 5.1.3.1. Innovations of technologically advanced lancet devices
- 5.1.3.2. Rapid adoption of home based healthcare and telemedicine
- 5.1.4. Challenges
- 5.1.4.1. Stringent government regulations associated with lancet use and marketing
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of COVID-19
- 5.5. Cumulative Impact of Russia-Ukraine Conflict
- 5.6. Cumulative Impact of High Inflation
- 5.7. Porter’s Five Forces Analysis
- 5.7.1. Threat of New Entrants
- 5.7.2. Threat of Substitutes
- 5.7.3. Bargaining Power of Customers
- 5.7.4. Bargaining Power of Suppliers
- 5.7.5. Industry Rivalry
- 5.8. Value Chain & Critical Path Analysis
- 5.9. Regulatory Framework
- 5.10. Client Customization
- 6. Blood Lancet Market, by Type
- 6.1. Introduction
- 6.2. Home Care Lancet
- 6.3. Safety Lancets
- 6.4.1. Manually
- 6.4.2. Pressure Activated
- 6.4. Standard Lancets
- 7. Blood Lancet Market, by Gauze Size
- 7.1. Introduction
- 7.2. 22G
- 7.3. 31 G
- 7.4. Above 38 G
- 7.5. Below
- 8. Blood Lancet Market, by Age Group
- 8.1. Introduction
- 8.2. Adult
- 8.3. Pediatrics
- 9. Blood Lancet Market, by End-Users
- 9.1. Introduction
- 9.2. Blood Banks
- 9.3. Home Care
- 9.4. Hospitals & Clinics
- 10. Blood Lancet Market, by Application
- 10.1. Introduction
- 10.2. Cholesterol Testing
- 10.3. Glucose Testing
- 10.4. Hemoglobin Testing
- 11. Americas Blood Lancet Market
- 11.1. Introduction
- 11.2. Argentina
- 11.3. Brazil
- 11.4. Canada
- 11.5. Mexico
- 11.6. United States
- 12. Asia-Pacific Blood Lancet Market
- 12.1. Introduction
- 12.2. Australia
- 12.3. China
- 12.4. India
- 12.5. Indonesia
- 12.6. Japan
- 12.7. Malaysia
- 12.8. Philippines
- 12.9. Singapore
- 12.10. South Korea
- 12.11. Taiwan
- 12.12. Thailand
- 12.13. Vietnam
- 13. Europe, Middle East & Africa Blood Lancet Market
- 13.1. Introduction
- 13.2. Denmark
- 13.3. Egypt
- 13.4. Finland
- 13.5. France
- 13.6. Germany
- 13.7. Israel
- 13.8. Italy
- 13.9. Netherlands
- 13.10. Nigeria
- 13.11. Norway
- 13.12. Poland
- 13.13. Qatar
- 13.14. Russia
- 13.15. Saudi Arabia
- 13.16. South Africa
- 13.17. Spain
- 13.18. Sweden
- 13.19. Switzerland
- 13.20. Turkey
- 13.21. United Arab Emirates
- 13.22. United Kingdom
- 14. Competitive Landscape
- 14.1. FPNV Positioning Matrix
- 14.2. Market Share Analysis, By Key Player
- 14.3. Competitive Scenario Analysis, By Key Player
- 15. Competitive Portfolio
- 15.1. Key Company Profiles
- 15.1.1. Abbott Laboratories
- 15.1.2. ACON Laboratories, Inc.
- 15.1.3. AdvaCare Pharma
- 15.1.4. AMBISEA Technology Corp., Ltd.
- 15.1.5. Amkay Products Pvt. Ltd.
- 15.1.6. B. Braun Melsungen AG
- 15.1.7. Becton, Dickinson & Company
- 15.1.8. BioCare Corporation
- 15.1.9. CML Biotech Ltd.
- 15.1.10. F. Hoffmann-La Roche AG
- 15.1.11. FL MEDICAL s.r.l.
- 15.1.12. Haemonetics Corporation
- 15.1.13. Improve Medical
- 15.1.14. Natus Medical by ARCHIMED
- 15.1.15. Nipro Medical Corporation
- 15.1.16. Owen Mumford Ltd.
- 15.1.17. SARSTEDT AG & Co. KG
- 15.1.18. Shandong Lianfa Medical Plastic Products Co., Ltd.
- 15.1.19. SteriLance Medical (Suzhou) Inc.
- 15.1.20. Terumo Corporation
- 15.1.21. Ypsome AD
- 15.2. Key Product Portfolio
- 16. Appendix
- 16.1. Discussion Guide
- 16.2. License & Pricing
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.